|
Volumn 17, Issue 9, 2007, Pages 2430-2433
|
Benzimidazol-2-yl or benzimidazol-2-ylthiomethyl benzoylguanidines as novel Na+/H+ exchanger inhibitors, synthesis and protection against ischemic-reperfusion injury
|
Author keywords
Benzoylguanidine derivatives; Myocardial ischemic reperfusion injury; Na+ H+ exchanger; Na+ H+ exchanger inhibitors; Synthesis
|
Indexed keywords
3 METHYLSULFONYLBENZOYLGUANIDINE;
BENZIMIDAZOLE DERIVATIVE;
CARIPORIDE;
GUANIDINE DERIVATIVE;
SODIUM PROTON EXCHANGE PROTEIN 1;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CELL SWELLING;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DISEASE MODEL;
DRUG DESIGN;
DRUG EFFECT;
DRUG EFFICACY;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HEART INFARCTION SIZE;
HEART MUSCLE ISCHEMIA;
HEART PROTECTION;
NONHUMAN;
RAT;
REACTION ANALYSIS;
REPERFUSION INJURY;
STRUCTURE ANALYSIS;
THROMBOCYTE;
ANIMALS;
BLOOD PLATELETS;
CHEMISTRY, PHARMACEUTICAL;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
GUANIDINES;
IMIDAZOLES;
INHIBITORY CONCENTRATION 50;
MODELS, CHEMICAL;
MOLECULAR CONFORMATION;
RATS;
REPERFUSION INJURY;
SODIUM-HYDROGEN ANTIPORTER;
|
EID: 33947727275
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2007.02.035 Document Type: Article |
Times cited : (24)
|
References (7)
|